Pharma Mirror Magazine

Indegene expands global operations with new nearshore centers in Americas and Europe

January 26, 2022

PRINCETON, N.J. and BANGALORE, India, Indegene, a technology-led healthcare solutions provider today announced it established new Global Development Centers in

Pharmaceutical News

Checkpoint Therapeutics Announces Positive Topline Results from the Registration-Enabling Trial of Cosibelimab

January 26, 2022

Waltham, Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced positive topline results from

Pharmaceutical News

Fermenta has signed a Definitive Agreement with Aurigene, a stepdown subsidiary of Dr Reddy’s Laboratories Limited

January 22, 2022

Fermenta Biotech Limited (FBL) today announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a

Pharmaceutical News

Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases

January 18, 2022

BARCELONA, Spain, a global biopharmaceutical company focused on skin health, and IRB Barcelona (the Institute for Research in Biomedicine), an independent,

Pharmaceutical News

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

January 18, 2022

ADELAIDE, Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has secured a significant investment from

Pharmaceutical News

Botanical Solution Inc. (BSI) Secures $6.1 Million in Series A First Closing

January 17, 2022

January 17, 2022 (Davis, CA) – Botanical Solution Inc. (BSI), innovator of sustainable, consistent, and cost-effective Advanced Botanical Materials for

MORE NEWS

Indegene expands global operations with new nearshore centers in Americas and Europe

Checkpoint Therapeutics Announces Positive Topline Results from the Registration-Enabling Trial of Cosibelimab

Fermenta has signed a Definitive Agreement with Aurigene, a stepdown subsidiary of Dr Reddy’s Laboratories Limited

Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

Botanical Solution Inc. (BSI) Secures $6.1 Million in Series A First Closing